PERMANENT RECORD · LEDGER-SCHEMA-1.0
LEDGER — 2026-07-09
00Commit record
- sha256
- e667bcd24941584c59b1356587fe18adfb9d3880a7481f9b9f37094529972230
- sealed_at
- 2026-07-10T13:29:16-04:00
- published_at
- 2026-07-09T16:05:00-04:00
- schema
- LEDGER-SCHEMA-1.0
01Regime
Regime: risk_on
02The sealed table
Rendered verbatim from the sealed file. All 25 rows are included, Pass rows are never filtered out.
LONG
| TICKER | CES | TIER | KVD | CAT | AGE | POS |
|---|---|---|---|---|---|---|
| $ALNY | 60 | Quality | Amvuttra ATTR-CM franchise share/peak sales | clinical_data | 0 | none |
| $SMPL | 35 | Marginal | organic net-sales trajectory + gross margin | earnings_beat | 0 | none |
| $VRAX | 35 | Marginal | commercial supply agreements / first revenue | contract_win | 0 | none |
| $BBIO | 33 | Marginal | Attruby ATTR-CM script ramp / stabilizer SOC position | clinical_data | 0 | none |
| $AZZ | 18 | Marginal | FY27 forward revenue/EBITDA guide + Metal Coatings volume | guidance_raise | 1 | none |
| $AP | 15 | Pass | committed-demand / order backlog | contract_win | 1 | none |
| $RKTO | 15 | Pass | narrative / AI association - no measurable KVD | other | 0 | none |
| $RPGL | 12 | Pass | listing-status overhang (not a business KVD) | other | 0 | none |
| $FCEL | 10 | Pass | committed demand / platform economics | partnership | 0 | none |
| $ENVX | 9 | Pass | manufacturing yield / scale-up execution | other | 0 | none |
| $AMAT | 8 | Pass | WFE capex cycle / leading-edge intensity | analyst_initiation | 0 | none |
| $GLSI | 8 | Pass | FLAMINGO-01 Phase III readout (unchanged) | regulatory | 0 | none |
| $SUNE | 6 | Pass | ownership/flow disclosure (not a business KVD) | other | 0 | none |
| $MU | 4 | Pass | AI/HBM memory pricing & forward bookings | other | 0 | none |
SHORT
| TICKER | CES | TIER | KVD | CAT | AGE | ANCH | POS |
|---|---|---|---|---|---|---|---|
| $IONS | 60 | Quality | eplontersen ATTR-CM expansion opportunity | regulatory_rejection | 0 | — | none |
| $AZN | 47 | Quality | Wainua ATTR-CM franchise option value | regulatory_rejection | 0 | — | none |
| $BYRN | 23 | Marginal | e-commerce conversion + dealer/chain reorder revenue | earnings_miss | 0 | — | none |
| $RXT | 16 | Marginal | FY26 revenue/EBITDA guide + capital structure | guidance_cut | 0 | — | none |
| $MDA | 14 | Pass | share count / capital structure (structural KVD) | offering_dilution | 0 | — | none |
| $PEP | 13 | Pass | PFNA (Frito-Lay NA) organic revenue & volumes | kpi_deterioration | 0 | — | none |
| $IBM | 11 | Pass | software+consulting AI-disintermediation risk (no measured delta) | analyst_downgrade | 0 | — | none |
| $META | 10 | Pass | capex intensity & FCF trajectory | margin_compression | 0 | — | none |
| $LEVI | 9 | Pass | Levis brand organic growth + gross margin - INTACT/ACCELERATING | earnings_miss | 0 | — | none |
| $TRNR | 6 | Pass | share count / going concern (structural KVD, NO dated anchor) | offering_dilution | 0 | — | none |
| $PLTR | 5 | Pass | US commercial growth / NDR - INTACT | analyst_downgrade | 0 | — | none |
03KVD notes
$ALNY — Quality — CES 60
Competitor eplontersen (AZ/Ionis) CARDIO-TTRansform Ph3 missed primary endpoint (no effect on stabilizer background); Amvuttra left as sole outcomes-proven TTR silencer in ATTR-CM.
$IONS — Quality — CES 60
7/9 pre-mkt: CARDIO-TTRansform Ph3 of eplontersen (Wainua) in ATTR-CM MISSED the primary composite endpoint (CV mortality + recurrent CV events to Wk140). Pre-specified monotherapy subgroup nominally significant HR 0.71; safety favorable; full data at ESC Aug-2026.
$AZN — Quality — CES 47
7/9 pre-mkt: partner Ionis + AZ announce CARDIO-TTRansform Ph3 (Wainua/eplontersen, ATTR-CM) missed primary endpoint. ATTR-CM was AZs largest cardiometabolic expansion option; ALNY +15% pre-mkt on the read-across.
04Position disclosure
| TICKER | SIDE | TIER | AUTHOR POSITION |
|---|---|---|---|
| $ALNY | LONG | Quality | none |
| $IONS | SHORT | Quality | none |
| $AZN | SHORT | Quality | none |
| $SMPL | LONG | Marginal | none |
| $VRAX | LONG | Marginal | none |
| $BBIO | LONG | Marginal | none |
| $BYRN | SHORT | Marginal | none |
| $AZZ | LONG | Marginal | none |
| $RXT | SHORT | Marginal | none |
| $AP | LONG | Pass | none |
| $RKTO | LONG | Pass | none |
| $MDA | SHORT | Pass | none |
| $PEP | SHORT | Pass | none |
| $RPGL | LONG | Pass | none |
| $IBM | SHORT | Pass | none |
| $FCEL | LONG | Pass | none |
| $META | SHORT | Pass | none |
| $LEVI | SHORT | Pass | none |
| $ENVX | LONG | Pass | none |
| $AMAT | LONG | Pass | none |
| $GLSI | LONG | Pass | none |
| $TRNR | SHORT | Pass | none |
| $SUNE | LONG | Pass | none |
| $PLTR | SHORT | Pass | none |
| $MU | LONG | Pass | none |
05Prior-session outcomes
No prior-session outcomes exist in the record. This is the first session of the series.
06What the system got wrong
No outcomes exist to review. There were no Prime-tier misses.
07Running calibration
No labeled outcomes exist yet.
| TIER | n | CORRECT | HIT% | MEAN IDIO |
|---|---|---|---|---|
| Prime | 0 | 0 | — | — |
| Quality | 0 | 0 | — | — |
| Marginal | 0 | 0 | — | — |
| Pass | 0 | — | — | — |
Sample below significance threshold (n<100/tier).
08Verify
The reader does not trust; the reader checks.
$ curl -sO https://rcacatalyst.vip/ledger/2026-07-09.json $ sha256sum 2026-07-09.json e667bcd24941584c59b1356587fe18adfb9d3880a7481f9b9f37094529972230 This hash was published before the opening bell, at 13:29:16 ET, and has not changed.
09Disclaimer & immutability
This is an impersonal publication of general and regular circulation. It is not investment advice, is not tailored to any person, and creates no advisory or fiduciary relationship. No entry, exit, or position sizing guidance is given. Author positions are disclosed per row.
IMMUTABILITY: rows are never edited after publication. Corrections are appended below, dated and timestamped. The original text and the original hash remain.